EVLO · Categories · Form 4

EVLO - SEC Form 4 insider transactions

Evelo Biosciences Inc. (EVLO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for EVLO

• 945d
  Bodmer Mark converted options into 6,625 shares and sold $1,044 worth of shares (3,163 units at $0.33), increasing direct ownership by 16% to 25,732 units (SEC Form 4)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 945d
  Mchale Duncan converted options into 6,500 shares and sold $1,024 worth of shares (3,103 units at $0.33), increasing direct ownership by 25% to 16,984 units (SEC Form 4)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 945d
  Gill Simba sold $57 worth of shares (172 units at $0.33) and converted options into 1,172 shares, increasing direct ownership by 6% to 17,758 units (SEC Form 4)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 945d
  Thorell Marella converted options into 6,500 shares and sold $598 worth of shares (1,811 units at $0.33), increasing direct ownership by 27% to 22,259 units (SEC Form 4)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 950d
  Bodmer Mark sold $2,262 worth of shares (6,854 units at $0.33) and converted options into 12,500 shares, increasing direct ownership by 34% to 22,270 units (SEC Form 4)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 950d
  Mchale Duncan converted options into 12,500 shares and sold $2,262 worth of shares (6,854 units at $0.33), increasing direct ownership by 71% to 13,587 units (SEC Form 4)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 950d
  Thorell Marella converted options into 12,500 shares and sold $1,320 worth of shares (3,999 units at $0.33), increasing direct ownership by 94% to 17,570 units (SEC Form 4)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 985d
  Gill Simba sold $7,864 worth of shares (1,996 units at $3.94) and converted options into 15,000 shares, increasing direct ownership by 346% to 16,758 units (SEC Form 4)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1001d
  SEC Form 4 filed by Bodmer Mark

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1001d
  SEC Form 4 filed by Thorell Marella

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1001d
  SEC Form 4 filed by Mchale Duncan

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1036d
  SEC Form 4: Bodmer Mark sold $29,747 worth of shares (3,128 units at $9.51) and converted options into 6,625 shares, increasing direct ownership by 27% to 16,624 units

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1036d
  SEC Form 4: Gill Simba converted options into 1,171 shares and sold $3,252 worth of shares (342 units at $9.51), increasing direct ownership by 28% to 3,754 units

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1036d
  SEC Form 4: Mchale Duncan converted options into 6,500 shares and sold $32,657 worth of shares (3,434 units at $9.51), increasing direct ownership by 63% to 7,941 units

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1036d
  SEC Form 4: Thorell Marella converted options into 6,500 shares and sold $19,058 worth of shares (2,004 units at $9.51), increasing direct ownership by 98% to 9,069 units

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1063d
  SEC Form 4 filed by Flagship Ventures Fund Iv General Partner Llc

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1064d
  SEC Form 4 filed by Reynolds Alexander C

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1064d
  SEC Form 4 filed by Moore Jeffrey R.

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1094d
  SEC Form 4 filed by Williams Tonya

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1094d
  SEC Form 4 filed by Gutierrez-Ramos Jose-Carlos

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1094d
  SEC Form 4 filed by Hohneker John

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1094d
  SEC Form 4 filed by Mchugh Julie

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1094d
  SEC Form 4 filed by Mcinnes Iain B.

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1094d
  SEC Form 4 filed by Melas Kyriazi Theo

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1094d
  SEC Form 4 filed by Andres Juan

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1094d
  SEC Form 4 filed by Rosiello Robert L.

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1094d
  SEC Form 4 filed by Gill Simba

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1094d
  SEC Form 4 filed by Bodmer Mark

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1127d
  SEC Form 4 filed by Mchale Duncan

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1127d
  SEC Form 4 filed by Bodmer Mark

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1127d
  SEC Form 4 filed by Thorell Marella

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1127d
  SEC Form 4 filed by Gill Simba

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1127d
  SEC Form 4 filed by Gill Simba (Amendment)

  4/A - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1128d
  SEC Form 4 filed by Gill Simba

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1128d
  SEC Form 4 filed by Thorell Marella

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1128d
  SEC Form 4 filed by Mchale Duncan

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1149d
  SEC Form 4 filed by Rosiello Robert L.

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1217d
  SEC Form 4 filed by Gill Simba

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1217d
  SEC Form 4 filed by Bodmer Mark

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1217d
  SEC Form 4 filed by Mchale Duncan

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1217d
  SEC Form 4 filed by Thorell Marella

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1224d
  SEC Form 4: Plinio Mark D. was granted 1,250 shares, increasing direct ownership by 50% to 3,750 units

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1234d
  SEC Form 4: Carriere Stephen J converted options into 354 shares and sold $160 worth of shares (151 units at $1.06) (for tax liability)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1335d
  SEC Form 4 filed by Char Daniel

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1335d
  SEC Form 4 filed by Zung Jonathan B.

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1335d
  SEC Form 4: Plinio Mark D. was granted 1,250 shares, increasing direct ownership by 100% to 2,500 units

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1378d
  SEC Form 4 filed by Thorell Marella

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1441d
  SEC Form 4: Epstein David R converted options into 4,927 shares, increasing direct ownership by 6% to 93,932 units

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1458d
  SEC Form 4 filed by Melas Kyriazi Theo

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1458d
  SEC Form 4 filed by Mcinnes Iain B.

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1458d
  SEC Form 4 filed by Mchugh Julie

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1458d
  SEC Form 4 filed by Hohneker John

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1458d
  SEC Form 4 filed by Epstein David R

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1458d
  SEC Form 4 filed by Darzi Lord Ara

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1458d
  SEC Form 4 filed by Andres Juan

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1470d
  SEC Form 4: Flagship Ventures Fund Iv General Partner Llc bought $39,999,998 worth of shares (27,397,259 units at $1.46)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1470d
  SEC Form 4: Epstein David R converted options into 4,925 shares, increasing direct ownership by 6% to 89,005 units

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1471d
  SEC Form 4: Mchale Duncan bought $49,999 worth of shares (34,246 units at $1.46)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1471d
  SEC Form 4: Darzi Lord Ara bought $499,999 worth of shares (342,465 units at $1.46)

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
• 1471d
  SEC Form 4: Epstein David R bought $25,000 worth of shares (17,123 units at $1.46), increasing direct ownership by 26% to 84,080 units

  4 - Evelo Biosciences, Inc. (0001694665) (Issuer)

Other EVLO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends